Back
Regeneron Pharmaceuticals Vs. Eli Lilly and Industry Stock Comparison
Buy
59
REGN
Regeneron Pharmaceuticals
Last Price:
907.34
Seasonality Move:
10.55%
Buy
54
LLY
Eli Lilly and
Last Price:
745.13
Seasonality Move:
3.18%
Buy
59
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $900.16. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $731.33. The Score for LLY is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $900.16
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $731.33
The current trend is relatively stagnant and LLY is experiencing slight selling pressure.
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -17.16 | Sell |
| Relative Strength Index (14 RSI): | 32.53 | Sell |
| Chaikin Money Flow: | -172250 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (910.74 - 966.14) | Sell |
| Bollinger Bands (100): | (873.95 - 970.85) | Sell |
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.64 | Sell |
| Relative Strength Index (14 RSI): | 38.41 | Sell |
| Chaikin Money Flow: | -116403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (748.16 - 777.1) | Sell |
| Bollinger Bands (100): | (610.46 - 768.18) | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 901.17 | Sell |
| 20-day SMA: | 931.75 | Sell |
| 50-day SMA: | 951.9 | Sell |
| 200-day SMA: | 860.19 | Buy |
| 8-day EMA: | 905.26 | Sell |
| 20-day EMA: | 924.16 | Sell |
| 50-day EMA: | 935.33 | Sell |
| 200-day EMA: | 875.1 | Buy |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 745.39 | Sell |
| 20-day SMA: | 760.83 | Sell |
| 50-day SMA: | 762.17 | Sell |
| 200-day SMA: | 616.85 | Buy |
| 8-day EMA: | 744 | Sell |
| 20-day EMA: | 754.02 | Sell |
| 50-day EMA: | 742.39 | Sell |
| 200-day EMA: | 628.39 | Buy |
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.25 per share, an increase next quarter of $0.01 per share, an increase this year of $2.51 per share, and an increase next year of $2.21 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.58 per share, an increase next quarter of $0.02 per share, an increase this year of $6.19 per share, and an increase next year of $5.66 per share.
Regeneron Pharmaceuticals Technical Analysis
| Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Eli Lilly and Technical Analysis
| Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||